Myotic Dystrophy Treatment Breakthrough

PLUS: Mysteries Surround Ehlers-Danlos Syndrome

Hi friends 👋🏼,

From cancer to blindness - gene therapy is revolutionizing medicine. We’ve got four stories for you this week, taking three of your requests:

  • Myotic Dystrophy Treatment Breakthrough READER REQUEST

  • Mysteries Surround Ehlers-Danlos Syndrome READER REQUEST

  • Measles to Kill Medulloblastoma READER REQUEST

  • Let There Be Light: Gene Therapy for Blindness

Upgrade to Premium for access to weekly articles and to make custom requests from our team of scientists.

(if you’re already a premium member, ignore this little box)

 

✋🏼🤚🏼 Myotonic Dystrophy Treatment Breakthrough

Congenital Myotonic Dystrophy (CMD) is an inherited genetic disorder characterized by progressive muscle wasting and weakness, among other symptoms. For example, imagine opening a door and having difficulty releasing your grip on the doorknob.

1/ CMD is caused by a mutated DMPK gene. Specifically, sections of the DMPK gene are incorrectly repeated thousands of times. As a result, the abnormally large gene produces an unusually large mRNA, producing a nonfunctional protein that causes the disease.

2/ Avidity Biosciences has developed AOC 1001, designed to address CMD's root cause.

Here’s how AOC 1001 works👇🏼

Subscribe to Premium to read the rest.

Become a paying subscriber of Premium to get access to this post and other subscriber-only content.

Already a paying subscriber? Sign In.

A subscription gets you:

  • • Submit your disease request and we'll find and report on clinical trials, emerging medical technology, and innovative therapeutics.
  • • Easy to understand science written for the everyday person.
  • • Articles delivered to your inbox every Sunday.
  • • Plus - No ads. Ever.